US Stocks
/
Cellectar Biosciences, Inc. Share Price
Cellectar Biosciences, Inc. Share Price

Cellectar Biosciences, Inc. Share Price

NASDAQ: CLRB | Micro Cap
$1.38
-$0.14 (-9.21%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Cellectar Biosciences, Inc. Stock Performance

Open
$1.46
Prev. Close
$1.52
Circuit Range
N/A
Day Range
$1.34 - $1.46
Year Range
$1.34 - $5.13
Volume
3,260
Average Traded
$1.40

Cellectar Biosciences, Inc. Share Price Today

As of 9 October 2026, Cellectar Biosciences, Inc.'s share price is $1.38. The stock opened at $1.46, compared to its previous close of $1.52. During today's trading session, Cellectar Biosciences, Inc.'s share price traded between $1.34 and $1.46, with an average price of $1.40. Over the past 52 weeks, the stock has recorded a high of $5.13 and a low of $1.34. In terms of performance, Cellectar Biosciences, Inc.'s share price has declined by 47.53% over the last six months and is down 59.29% on a year-on-year basis.

Cellectar Biosciences, Inc. Share Price Chart

$1.34$1.46
L
Show Current Price
H

Cellectar Biosciences, Inc. Stock Fundamentals & Key Indicators

Market Cap
$3.60M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.36
Revenue (TTM)
$0.00
Return On Equity (TTM)
-74.73%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-56.08%

Cellectar Biosciences, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$4.44-$5.30-$5.65-$6.93
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-19.37%-6.60%-22.65%

Cellectar Biosciences, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$31.79-$42.77-$44.58-$21.79
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-34.54%-4.23%51.12%

About Cellectar Biosciences, Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. The products under development include Iopofosine, CLR 121125 ,CLR 121225 and others. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

Cellectar Biosciences, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$1.86
$1.37
-25.54%
Sep 2026
$2.45
$1.84
-26.98%
Aug 2026
$2.60
$2.52
-3.82%
Jul 2026
$2.83
$2.62
-6.43%
Jun 2026
$3.12
$2.80
-13.04%
May 2026
$2.64
$3.22
+22.43%
Apr 2026
$2.87
$2.63
+6.48%
Mar 2026
$3.02
$2.47
-26.27%
Feb 2026
$3.11
$3.35
+5.68%
Jan 2026
$3.56
$3.17
+9.31%
Dec 2025
$3.58
$2.90
-19.67%
Nov 2025
$3.26
$3.61
+6.49%

CLRB Share Price FAQs

What is Cellectar Biosciences, Inc. share price today?

chevron-up
Cellectar Biosciences, Inc. share price today is $1.38 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Cellectar Biosciences, Inc. stock?

chevron-up
The 52 week high of Cellectar Biosciences, Inc. stock is $5.13, while the 52 week low is $1.34 as of 9 Oct '26.

What is CLRB's market capitalisation today?

chevron-up
CLRB market capitalisation is $3.60M as of October 9, 2026, at 11:45 am IST.

What is CLRB's net income for the last quarter?

chevron-up
CLRB's net income for the last quarter is -6.93B USD.

What is the 5 year returns of CLRB?

chevron-up
The 5 year returns of CLRB is -99.48% as on 9 Oct '26.

What is the high & low stock price of CLRB today?

chevron-up
CLRB stock price hit a high of $1.46 and low of $1.34 as of 9 Oct '26.

Can I buy CLRB shares in India?

chevron-up
Yes. You can buy CLRB in India by opening an international trading account.